Table 1.
Patient characteristics and distribution of prosthetic valve types
| Number of patients completing TTE and CMR | 18 |
| Gender (male/female) | 7/11 |
| Mean age (range) at study enrollment [years] | 73.7 ± 5.7 (64.0 - 82.8) |
| Mean time (range) since mitral valve replacement [years] | 4.9 ± 3.5 (0.6 - 10.9) |
| Mean left ventricular ejection fraction (range) [%] | 44.6 ± 15.3 (10 - 64) |
| Mean left atrial area [cm2] | 31.1 ± 11.1 (18-58) |
| Native mitral valvular lesion | |
| Mitral regurgitation | 11 |
| Mitral stenosis | 4 |
| Combined mitral lesion | 3 |
| Heart rhythm | |
| Sinus rhythm | 6 |
| Atrial fibrillation | 11 |
| Frequent ventricular extrasystoles | 1 |
| Prosthetic types | |
| Medtronic Hancock® | 13 |
| Labcore® | 4 |
| Carpentier Edwards Perimount® | 1 |
| Prosthetic sizes | |
| 27 | 4 |
| 29 | 7 |
| 31 | 6 |
| 33 | 1 |